Skip to content
15% off your first order15% off your first order

NAD+ 500 mg vial

Cellular energy

Investigated for redox balance and cellular energy.

$99.00CAD· $0.20/mg
Format. Vial or pen?
1
  • Ships from Canada in 1–2 business days
  • Free shipping over $120
  • Place your order, then send the e-Transfer. We pack it as soon as it arrives.

For research use only. Not for human consumption.

Complete your setup

Needles and wipes are free. Water is $19.

Compare. Side by side, from the research.

About NAD+

NAD+ is a coenzyme central to how cells convert fuel into usable energy. Research examines its role in redox reactions, mitochondrial output, and the repair pathways associated with biological aging.

How it works

Redox Carrier
Cycles between oxidized and reduced forms to shuttle electrons through the reactions generating cellular energy.
Sirtuin Substrate
Consumed by sirtuin enzymes, linking NAD+ availability to signaling around mitochondrial upkeep and stress response.
Read the full research

What you need

  • Bacteriostatic Water
  • Needles
  • Alcohol Wipes
  • A protocol guide comes with every order

Shipping & payment

  • Packed and dispatched within 1–2 business days
  • Delivered across Canada in 2–5 business days, tracked
  • Temperature-controlled packaging where the product needs it
  • Free shipping on orders over $120
  • Prices in CAD · pay by Interac e-Transfer
Format
Lyophilised powder in a sealed vial
Strength
500 mg per vial
Storage
Refrigerate, away from light. Once reconstituted, keep refrigerated and use within the window on the insert.
Reconstitution
2 mL bacteriostatic water for this 500 mg vial (250 mg/mL)
Route in research
Subcutaneous
SKU
NJ500

Handling

  1. 1ReconstituteAdd bacteriostatic water down the side of the vial. Swirl, never shake. Agitation damages the peptide chain.
  2. 2StoreRefrigerate at 2–8°C once mixed. Reconstituted peptide is stable for the window given in your protocol guide.
  3. 3Measure with the calculator Use an insulin syringe at the units your protocol specifies. Rotate sites and log what you take.
Purity
High-performance liquid chromatography (HPLC), by an independent laboratory
Identity
Mass spectrometry, on the same batch
How often
Every batch
COA
The certificate of analysis is matched to the lot code printed on your vial
Evidence
Early clinical

Check your lot

Every vial carries a lot code. Enter it, or scan the QR on the label, to see its expiry and certificate of analysis.

Early clinicalNAD+ biology is well characterized in reviews and animal work, and small randomized human trials have examined NAD+-boosting precursors such as NMN, while controlled human data on subcutaneous NAD+ itself remain limited.

What research examines

  • Cellular energy metabolism and redox reactions
  • Sirtuin activity in aging and disease
  • Aging-related metabolic decline and neurodegeneration
  • Blood-brain barrier integrity in aging animal models
  • Muscle insulin sensitivity in human trials of the precursor NMN

Reported in studies

  • Human safety data for subcutaneous NAD+ are limited
  • Safety of the precursor NMN has been reviewed across human clinical trials
  • A review has raised safety questions about NMN marketed as an anti-aging product
  • Adverse events for NAD+ itself are not summarized in the cited studies
Read the full research page· 5 cited studies

Published research protocols

100 mg, 3x/week, am

Research protocols have used 50–200 mg per administration, 3 times per week (morning). Reported cycle: continuous.

For research use only. These figures summarize published research protocols. They are not instructions or medical advice.

Measure with the calculator

CoreX AI

Ask about NAD+

Plain answers, from the basics to the studies.

Research information, not medical advice.

Often researched with NAD+

Researched for longevity & renewal.

Shop Longevity & renewal

FAQ

Questions, answered

  • NAD+ (nicotinamide adenine dinucleotide) is a coenzyme found in cells that is central to converting nutrients into usable energy. Research examines its role in redox reactions, mitochondrial output, and repair pathways associated with biological aging. It is categorized as a longevity research compound, and reviews have discussed how NAD+ levels relate to aging, metabolism, and neurodegeneration.

  • NAD+ acts as an electron carrier, cycling between oxidized and reduced forms to shuttle electrons through the reactions that generate cellular energy. It is also a required substrate consumed by sirtuin enzymes, which are studied for metabolic regulation, mitochondrial upkeep, and stress response. This links NAD+ availability to cellular maintenance signaling, a relationship examined in reviews of NAD+ and sirtuins in aging and disease.

  • Research has studied NAD+ in the context of aging, metabolism, and neurodegeneration, largely through reviews and animal models. One animal study reported that NAD+ addressed aging-induced blood-brain barrier damage via the CX43-PARP1 axis. Human trials have mostly examined NAD+-boosting precursors, including a randomized trial of NMN in healthy middle-aged adults and one reporting increased muscle insulin sensitivity in prediabetic women.

  • Human safety data for subcutaneous NAD+ are limited, and adverse events for NAD+ itself are not summarized in the cited studies. Much of the available human safety information concerns the precursor NMN, whose safety has been reviewed across clinical trials. At least one review has also discussed both promises and safety concerns of NMN as an anti-aging product, so findings should be interpreted cautiously.

  • Research protocols have used 50–200 mg per administration, 3 times per week in the morning, delivered subcutaneously, with a continuous reported cycle. These figures describe what protocols have used and are not recommendations. Each CoreX order ships with a protocol guide for laboratory reference. Related human trials of NAD+ precursors such as NMN have used oral supplementation rather than direct NAD+ administration.

Vial

Senescent-cell research

FOXO4 10 mg

$219/ 10 mg